Outset Medical, Inc.

OM Healthcare Medical Devices

Outset Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $119.5 million, up 5.09% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 6.73%, free cash flow fell 90.5% and total debt rose 4.20%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

3.94 0.14 −3.43%
Market cap
$76.6M
P/E
0.0×
Fwd P/E
−1.1×
Dividend yield
—
F-score
6/9
Altman Z
−5.37
Beneish M
−3.25
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
2.09 0.47 0.60 0.68
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(39.73) (5.93) (5.49) (8.35)
P/B ratio
1.81 0.44 0.63 0.83
Price to Tangible BV
1.81 0.44 0.63 0.83
EV/Sales
1.41 (0.13) 0.10 0.28
EV/EBITDA
0.00 0.24 0.00 0.00
EV/Operating CF
(3.17) 0.33 (0.35) (0.86)
EV/FCF
(3.13) 0.32 (0.35) (0.85)
Quick Ratio
5.65 5.24 4.84 4.02
Current Ratio
7.09 6.67 6.29 5.19
Net Debt/EBITDA
5.37 4.21 3.61 3.14
Debt/Assets
34.45% 36.39% 38.88% 40.76%
Debt/Equity
0.67 0.76 0.87 1.03
Asset Turnover
0.42 0.44 0.43 0.44
Operating CF/Net income
0.35 0.49 0.68 0.54
Capex/Depreciation
(0.50) (0.65) (0.17) (0.46)
Interest Coverage
(4.55) (5.12) (5.02) (4.55)
Research and Development Expense of Revenue
18.27% 17.51% 20.16% 17.23%
Selling, General and Administrative Expense of Revenue
74.84% 85.91% 83.97% 74.31%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
17.26% 14.07% 12.39% 8.52%
Graham Net Nets
0.52 2.01 1.40 1.02
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(92.40%) (183.02%) (108.33%) (94.68%)
Free Cash Flow Yield
(21.47%) (83.51%) (48.54%) (48.34%)
Revenue per Share
1.66 1.90 1.52 1.70
Operating CF per Share
(0.36) (0.63) (0.70) (0.52)
Capex per Share
(0.01) (0.01) 0.00 (0.01)
Free Cash Flow per Share
(0.36) (0.64) (0.70) (0.52)
Cash per Share
10.05 11.11 8.53 7.91
Shareholders Equity per Share
8.01 8.35 6.08 5.17
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
8.01 8.35 6.08 5.17
Free Cash Flow
(6.48) (9.74) (12.91) (9.75)
Working Capital
227.92 213.25 199.10 183.96
Capital Expenditures
(0.16) (0.22) (0.06) (0.11)
Net Current Asset Value
130.48 113.34 98.94 81.80
EV/EBIT
0.00 0.23 0.00 0.00
Capex to Sales
0.01 0.01 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
33.61 31.97 31.11 32.06
Average Payables
3.01 2.21 1.31 2.95
Average Inventory
55.36 53.50 52.71 49.78
Average Assets
285.07 270.15 275.33 265.59
Average Common Equity
93.17 76.89 138.86 123.64

Fold the line items

Columns are period end dates